Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

MHRA recalls Carbimazole10mg and 15mg tablets

The Medicines and Health products Regulatory Agency (MHRA) has recalled Carbimazole 10mg and 15mg tablets of Advanz Pharma with PL 20072/0244 and PL 20072/0245.

Advanz Pharma is recalling the two batches of carbimazole tablets as a precautionary measure, due to an out of specification observation for tablet appearance of samples during routine stability testing.


“Based on the investigation performed, the observed defect was related to oxidation of the excipient red iron oxide on the surface of the tablets, due to a lack of proper mixing during the manufacturing process. There is no safety or efficacy issues as a result of this observation,” MHRA said.

Carbimazole 10mg tablets

Batch NumberExpiry DatePack SizeFirst Distributed
120963September 20211 x 10020th May 2020
121025September 20211 x 10019th January 2021

Carbimazole 15mg tablets

Batch NumberExpiry DatePack SizeFirst Distributed
120967September 20211 x 10026th June 2020
121028September 20211 x 10027th May 2020

Community pharmacy teams have been advised to stop supplying the two batches listed above immediately and return it to their supplier using supplier’s approved process.